Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $64.67 Consensus Price Target from Brokerages
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received a consensus rating of “Buy” from the ten analysts that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, six have given a buy rating and three have given a strong buy rating to the company. […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received a consensus rating of “Buy” from the ten analysts that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, six have given a buy rating and three have given a strong buy rating to the company. […]
